ROS1 and non-small cell lung carcinoma: Furthermore, two-thirds of Asian patients with advanced NSCLC present with driver genes, including KRAS, BRAF, EGFR, MET, and ERBB2 mutations, as well as genomic rearrangements involving ALK, ROS1, RET, and NTRK (5, 6).